ORION Trademark

Trademark Overview

On Wednesday, September 2, 2015, a trademark application was filed for ORION with the United States Patent and Trademark Office. The USPTO has given the ORION trademark a serial number of 86745108. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 14, 2022. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The ORION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for others in the field of RNAi therapeutics for the treatment of hypercholesterolemia
orion

General Information

Serial Number86745108
Word MarkORION
Filing DateWednesday, September 2, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2020

Trademark Statements

Goods and ServicesConducting clinical trials for others in the field of RNAi therapeutics for the treatment of hypercholesterolemia

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, September 5, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlnylam Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, March 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 9, 2021SOU EXTENSION 1 GRANTED
Monday, August 9, 2021SOU EXTENSION 1 FILED
Monday, August 9, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 15, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, July 10, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 10, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 10, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 10, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 3, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, February 26, 2020ASSIGNED TO LIE
Saturday, August 3, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, January 9, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, May 30, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, November 24, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 22, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 22, 2017ASSIGNED TO LIE
Thursday, November 10, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, May 6, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, April 30, 2016ASSIGNED TO LIE
Tuesday, October 13, 2015LETTER OF SUSPENSION MAILED
Sunday, October 11, 2015SUSPENSION LETTER WRITTEN
Saturday, October 10, 2015ASSIGNED TO EXAMINER
Saturday, September 5, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 5, 2015NEW APPLICATION ENTERED

Related Keywords

orion therapeutics treatment hypercholesterolemia rnai field clinical trials others conducting